Børge Sørvoll
Fortune : 244 676 $ au 31/05/2026
Fortune : 244 676 $ au 31/05/2026
Børge Sørvoll currently works at Biotec BetaGlucans AS, as Chairman and ArcticZymes Technologies ASA, as Chief Financial Officer from 2014.
Mr. Sørvoll also formerly worked at Troms Kraft Invest AS, as Managing Director & Chief Financial Officer, Front Exploration AS, as Chief Financial Officer, and Subsea 7 Norway AS, as Manager.
Mr. Sørvoll received his undergraduate degree from the University of Wyoming.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2024 | 100 428 ( 0,2 % ) | 244 676 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ARCTICZYMES TECHNOLOGIES ASA | Directeur Financier/CFO | 01/10/2014 |
Biotec BetaGlucans AS
Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Develops and manufactures immune modulating compounds for the human health sectors | Président | - |
| Sociétés | Poste | Fin |
|---|---|---|
Front Exploration AS
Front Exploration AS Contract DrillingIndustrial Services Explores oil and gas | Directeur Financier/CFO | - |
Subsea 7 Norway AS
Subsea 7 Norway AS Miscellaneous Commercial ServicesCommercial Services Engages in general trading activities | Corporate Officer/Principal | - |
Troms Kraft Invest AS | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
University of Wyoming
University of Wyoming Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ArcticZymes Technologies ASA
ArcticZymes Technologies ASA Medical SpecialtiesHealth Technology Develops and manufactures immune modulating compounds | Health Technology |
Front Exploration AS
Front Exploration AS Contract DrillingIndustrial Services Explores oil and gas | Industrial Services |
Subsea 7 Norway AS
Subsea 7 Norway AS Miscellaneous Commercial ServicesCommercial Services Engages in general trading activities | Commercial Services |
Troms Kraft Invest AS | |
Biotec BetaGlucans AS
Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Develops and manufactures immune modulating compounds for the human health sectors | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national